Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast Cancer

Breast cancer (BC) is the most common malignancy and second only to lung cancer in terms of mortality in women. Despite the incredible progress made in this field, metastatic breast cancer has a poor prognosis. In an era of personalized medicine, there is an urgent need for better knowledge of the b...

Descripción completa

Detalles Bibliográficos
Autores principales: Sobhani, Navid, Ianza, Anna, D’Angelo, Alberto, Roviello, Giandomenico, Giudici, Fabiola, Bortul, Marina, Zanconati, Fabrizio, Bottin, Cristina, Generali, Daniele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6071019/
https://www.ncbi.nlm.nih.gov/pubmed/30011957
http://dx.doi.org/10.3390/cells7070076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6071019/
https://www.ncbi.nlm.nih.gov/pubmed/30011957
http://dx.doi.org/10.3390/cells7070076

Ejemplares similares